These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39082516)

  • 1. Strengthening Multidrug-Resistant Tuberculosis Epidemiological Surveillance in Rio de Janeiro: a multidimensional analysis.
    Bhering M; Kritski A
    Rev Soc Bras Med Trop; 2024; 57():e00202. PubMed ID: 39082516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016.
    Bhering M; Duarte R; Kritski A
    PLoS One; 2019; 14(11):e0218299. PubMed ID: 31747405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
    BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
    Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
    Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study.
    Gallo JF; Pinhata JMW; Simonsen V; Galesi VMN; Ferrazoli L; Oliveira RS
    Clin Microbiol Infect; 2018 Aug; 24(8):889-895. PubMed ID: 29175351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory-based study of drug resistance and genotypic profile of multidrug-resistant tuberculosis isolates in Salvador, Bahia, Brazil.
    Sousa EO; Carneiro RTO; Montes FCOF; Conceição EC; Bartholomay P; Marinho JM; Lima KVB; Natividade MSD; Araújo WN; Matos ED; Barbosa T
    Rev Soc Bras Med Trop; 2022; 55():e00132022. PubMed ID: 35894395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.
    Marks SM; Flood J; Seaworth B; Hirsch-Moverman Y; Armstrong L; Mase S; Salcedo K; Oh P; Graviss EA; Colson PW; Armitige L; Revuelta M; Sheeran K;
    Emerg Infect Dis; 2014 May; 20(5):812-21. PubMed ID: 24751166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.
    Qi YC; Ma MJ; Li DJ; Chen MJ; Lu QB; Li XJ; Li JL; Liu W; Cao WC
    PLoS One; 2012; 7(2):e32103. PubMed ID: 22384153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug- and extensively drug-resistant tuberculosis, Germany.
    Eker B; Ortmann J; Migliori GB; Sotgiu G; Muetterlein R; Centis R; Hoffmann H; Kirsten D; Schaberg T; Ruesch-Gerdes S; Lange C;
    Emerg Infect Dis; 2008 Nov; 14(11):1700-6. PubMed ID: 18976552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China.
    He XC; Tao NN; Liu Y; Zhang XX; Li HC
    BMC Infect Dis; 2017 Aug; 17(1):555. PubMed ID: 28793873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients.
    Elion Assiana DO; Abdul JBPA; Linguissi LSG; Epola M; Vouvoungui JC; Mabiala A; Biyogho CM; Ronald Edoa J; Adegbite BR; Adegnika AA; Elton L; Canseco JO; McHugh TD; Ahombo G; Ntoumi F
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):84. PubMed ID: 34920727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
    Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
    Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
    Chand AB; Basnet A; Maharjan B; Rai G; Joshi YP; Bhatt LR; Sen B; Rai SK
    PLoS One; 2024; 19(5):e0301210. PubMed ID: 38709710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
    Stoffels K; Allix-Béguec C; Groenen G; Wanlin M; Berkvens D; Mathys V; Supply P; Fauville-Dufaux M
    PLoS One; 2013; 8(5):e63128. PubMed ID: 23671662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.